Pneumonia due to Stenotrophomonas maltophilia
DOI:
https://doi.org/10.51481/amc.v56i1.828Keywords:
Pneumonia, Stenotophomonas maltophilia, S. maltophilia, out-of-hospital infectionAbstract
Stenotrophomonas maltophilia is an emergent gram negative bacillus present in the environment. It has acquired relevance within a group of multidrug-resistant microorganisms as a cause of infection in different organs, both in hospitals and outside them. A case of respiratory failure with severe pneumonia due to S. maltophilia is reported. The immunocompetent patient got infected in the community and had a rapid response to trimethoprim sulphametoxazol once the bacteria were cultured.
Downloads
References
Hugh R, Leifsin E. A description of the type strain of Pseudomonas maltophilia. Int Bull Bacteriol Nomencl Taxon 1963;13:133-138
Sara Stamps, Aimee Zaas. Stenotrophomonas maltophilia. UpToDate, Inc. 2012.
W John Looney. Stenotrophomonas: An emerging opportunist human pathogen. Lancet Infect 2009; 9: 312-323
Victor MA, Arpi M, Brunn B, Jonsson V, Hansen MM. Xanthomonas maltophilia in immune compromised hematological patients. Scand J Infect Dis 1994; 26:163-170.
Jang TN, Wang LS, Liu CY. Xanthomonas maltophilia bacteremia:
an analysis of 32 cases. J Formos Med Assoc 1992; 91:1170-1176.
Lockhart SR. Antimicrobial resistance among gram negative Bacilli causing infections in intensive care unit patients in the United States between 1993-2004. J Clin Microbiol 2007; 45:3352-3359.
Razvi S. Respiratory microbiology of patients with cystic fibrosis in the United States 1995-2005. Chest 2009;136:1554-1560.
Jones RN. Microbiological etiologies of Hospital acquired bacterial pneumonia and ventilator associated bacterial pneumonia. Clin Infect Dis 2010;51:881-887.
Pearlman E, Butala S, Bilello L, Stauffer J. Stenotrophomona maltophilia (SM) in ambulatory patient population. 12th European Congress of Clinical Microbiology and infectious diseases. 2002 April 24-27, Milan, Italy. Abstract P1435.
Brooke Joanna S. Stenotrophomonas maltophilia: An Emerging Global Opportunistic Pathogen. Clinical Microbiol Rev 2012; Vol 25 No.1:2-41.
Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistance Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features and trends in the Sentry Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001; 32 Suppl 2:104-13.
Hae-Sung Chung, Seong Hong, Young ReeKim. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea and the activity of antimicrobial combinations against isolates. J Korean Med Society 2013 Vol 24 No.1:62-68.
Wai Kan KT, Ka Lok RL, LI A. Computed tomography features of Stenotrophomonas maltophilia pneumonia in patients with neutropenic fever: Report of two cases. Multidisc, Respiratory Medicine 2013; 8:14.
Li Xz, Zhang L, Poole K. Smec, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2002; 46:333-43.
Martinez JL. Antibiotics and antibiotic resistance genes in natural environments. Science 2008; 321:365-367.
Wood GC, Underwood EI, Crose MA, Swanson JM, Fabian TC. Treatment of Recurrent Stenotrophomonas maltophilia ventilator associated pneumonia with doxycycline and aerosolized colistin. Ann Pharmacother 2010; 44:1665-1668.
Downloads
Published
Versions
- 2014-01-30 (2)
- 2014-01-30 (1)
Issue
Section
License
Copyright (c) 2014 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
